These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5993790)

  • 1. [Aggregation and adhesiveness of blood platelets in the physiopathology and prevention of thrombophilic states. Prospects and results of experimental and clinical research].
    De Nicola P; Gibelli A; Frandoli G; Giarola P; Turazza G
    G Gerontol; 1966 Oct; 14(10):941-51. PubMed ID: 5993790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of chlorophenoxy-isobutyric ester on platelet adhesiveness and aggregation in the patients with arteriosclerosis and diabetes mellitus].
    Yasunaga K
    Naika Hokan; 1969 Oct; 16(10):393-403. PubMed ID: 5391800
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate].
    Frandoli G; Gibelli A; Giarola P
    Clin Ter; 1966 Jul; 38(1):27-38. PubMed ID: 4230052
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent progress in atherosclerosis research; experimental and clinical aspects.
    Clopath P; Dicato MA
    Bull Soc Sci Med Grand Duche Luxemb; 1978; 115(1):21-33. PubMed ID: 359186
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of thrombophilic states by prolonged activation of fibrinolysis].
    De Nicola P
    Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of the arterial wall in atherosclerosis. Trial with different drugs].
    Morelli AC
    Prensa Med Argent; 1965 Oct; 52(40):2571-81. PubMed ID: 5880902
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent studies on the mechanism and prevention of arterial thrombosis].
    Born GV
    J Pharmacol; 1982; 13 Suppl 1():21-8. PubMed ID: 7050539
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of pharmacologic agents in atherosclerosis therapy.
    Kritchevsky D
    Ann N Y Acad Sci; 1968 Nov; 149(2):1058-68. PubMed ID: 4890515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of atherosclerosis].
    Villaverde MM; Sadow HS
    Rev Clin Esp; 1967 Jan; 104(1):67-73. PubMed ID: 5596051
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in the development of antithrombotic agents.
    Hampton J
    Am J Cardiol; 1971 Jun; 27(6):659-69. PubMed ID: 4397351
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of arteriosclerosis with nicatol].
    Zharko KP
    Vrach Delo; 1968 Sep; 9():49-52. PubMed ID: 5740305
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical treatment of hyperlipemia. Indications and modern preparations].
    Frey H
    Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of a preparation containing unsaturated fatty acids on the course of experimental atherosclerosis in rabbits].
    Angarskaia MA; Sokolova VE; Liubartseva LA
    Farmakol Toksikol; 1972; 35(6):704-7. PubMed ID: 4651805
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-experimental studies of the influence of Atherolip on lipid and carbohydrate metabolism].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Med Welt; 1969 Aug; 31():1715-7. PubMed ID: 4895455
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimental lipid metabolism studies with essential phospholipids taking into account the arteriosclerosis problem].
    Hammerl H; Pichler O; Studlar M
    Wien Med Wochenschr; 1966 Apr; 116(16):348-52. PubMed ID: 5985190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Regelan (Atromid-S) on serum lipids and platelet aggregation in occlusive arterial disease].
    Fischer M; Irsigler K
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):248-51. PubMed ID: 4880993
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemical changes in atherosclerosis: current concepts and experimental applications].
    Porcellati G; Valcavi U; Gaiti A
    Minerva Med; 1971 Sep; 62(72):3414-30. PubMed ID: 4255471
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the use of Nicatol for the treatment of patients with atherosclerosis].
    Kushnir VE
    Vrach Delo; 1967 May; 5():76-9. PubMed ID: 5618549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.